Nasdaq · CIK 0001819411
GANX Gain Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Jun 25, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Signals
Open-market buys and sells at Gain Therapeutics, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 10 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | Dov A Goldstein Md director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 24, 2025 | Claude Nicaise director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 24, 2025 | Eric I Richman director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 24, 2025 | Gwen A Melincoff director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 24, 2025 | Hans Peter Hasler director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 24, 2025 | Jeffrey Scott Riley director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 24, 2025 | Khalid Islam director | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Mar 20, 2025 | Gianluca Fuggetta See Remark | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 21, 2025 |
| Mar 20, 2025 | Gene Mack CEO, President | AGrant or award Employee Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Mar 21, 2025 |
| Jan 6, 2025 | Gene Mack CEO, President | AGrant or award Stock Option (right to buy)derivative | +271,325 | $0.00 | $0 | 271,325 | Jan 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Gianluca FuggettaSee Remark
- Dov A Goldstein Mdcfo, officer, director
- Hans Peter Haslerdirector
- Khalid Islamdirector
- Gene MackCEO, President
- Gwen A Melincoffdirector
- Claude Nicaisedirector
- Eric I Richmandirector
- Jeffrey Scott Rileydirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.